Association of ABO and Rh blood groups with clinicopathological features and lymph node involvement in surgically treated thyroid malignancies: a retrospective single-center study.
6 affiliations
- 1Department of General Surgery, Hakkari Derecik State Hospital, Hakkari, Türkiye. [email protected].
- 2Department of General Surgery, Istanbul Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Türkiye. [email protected].
- 3Department of General Surgery, Muş Bulanık State Hospital, Muş, Türkiye.
- 4Department of General Surgery, Istanbul Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Türkiye.
- 5Department of General Surgery, Istanbul Buyukcekmece Mimar Sinan State Hospital, Istanbul, Türkiye.
- 6Department of General Surgery, Ankara Bilkent City Hospital, Ministry of Health, Ankara, Türkiye.
Abstract
This study investigated the association between ABO and Rh blood group antigens and the clinicopathological features of 418 patients who underwent thyroidectomy for primary thyroid malignancy between December 2016 and June 2023. Since continuous variables did not follow a normal distribution (p < 0.05), data were presented as median and interquartile range (IQR). The distribution of ABO blood groups was A (44.5%), O (31.8%), B (16.0%), and AB (7.7%), with 90.9% of patients being Rh-positive. The median age of the cohort was 48 years (IQR: 19). While ABO groups showed no significant difference in age, Rh-negative patients were significantly older than Rh-positive patients (52.5 vs. 48.0 years; p = 0.027). No direct association was identified between ABO groups and the overall clinicopathological features such as tumor size or multifocality (p > 0.05). However, significant differences were observed regarding pathologically confirmed lymph node (LN) involvement. Pathologically confirmed LN involvement was significantly more prevalent in the Rh-negative group compared to the Rh-positive group (15.8% vs. 5.5%; p = 0.027). Most notably, a subgroup analysis revealed that patients with the AB blood group had a significantly higher rate of pathologically confirmed LN involvement compared to non-AB groups (15.6% vs. 5.7%; p = 0.028). To confirm the independence of this association, a multivariable logistic regression analysis was performed. After adjusting for potential confounders including age and tumor size, the AB blood group was independently associated with pathologically confirmed LN metastasis in an exploratory multivariable model (OR: 3.114, 95% CI: 1.085-8.938, p = 0.035). These findings suggest that while ABO and Rh blood groups are not significantly associated with most clinicopathological variables in this cohort, they demonstrate specific correlations with nodal disease. These findings may represent exploratory signals that warrant further validation, rather than clinically applicable biomarkers at this stage. Further multicenter prospective studies are warranted to validate these associations across all histological subtypes.
Related
- Histopathological spectrum and clinicopathological profile of surgically treated central nervous system tumors at Assiut University Hospital: a 10-year retrospective study
- Association Between Tumor Budding and Lymph Node Metastasis in Surgically Resected Colon Cancer: A Retrospective Observational Study
- Study on the association between the low-density lipoprotein to high-density lipoprotein ratio and clinicopathological characteristics of breast cancer: A retrospective analysis incorporating subgroup evaluations by age, body mass index, and menopausal status
- Association of Clinicopathological Features With Locoregional Recurrence and Disease Outcomes Among Female Breast Cancer Patients at Tikur Anbessa Specialized Hospital, Ethiopia: A Hospital-Based Retrospective Cohort Study
- Hematologic breast malignancies: a single-institution cohort study of 24 patients diagnosed between January 2008 and June 2023, with clinicopathological and outcome analysis
BibTeX
@article{kaan2026association,
title = {{Association of ABO and Rh blood groups with clinicopathological features and lymph node involvement in surgically treated thyroid malignancies: a retrospective single-center study.}},
author = {Ahmet Zahit Kaan and Murat Acar and Harun Çok and Serhan Yılmaz and Erkan Somuncu},
journal = {BMC endocrine disorders},
year = {2026},
month = jul,
doi = {10.1186/s12902-026-02433-5},
url = {https://europepmc.org/article/MED/42894160},
note = {CC BY},
}
RIS
TY - JOUR
TI - Association of ABO and Rh blood groups with clinicopathological features and lymph node involvement in surgically treated thyroid malignancies: a retrospective single-center study.
AU - Ahmet Zahit Kaan
AU - Murat Acar
AU - Harun Çok
AU - Serhan Yılmaz
AU - Erkan Somuncu
PY - 2026
DA - 2026/07/01
JO - BMC endocrine disorders
DO - 10.1186/s12902-026-02433-5
UR - https://europepmc.org/article/MED/42894160
AB - This study investigated the association between ABO and Rh blood group antigens and the clinicopathological features of 418 patients who underwent thyroidectomy for primary thyroid malignancy between December 2016 and June 2023. Since continuous variables did not follow a normal distribution (p < 0.05), data were presented as median and interquartile range (IQR). The distribution of ABO blood groups was A (44.5%), O (31.8%), B (16.0%), and AB (7.7%), with 90.9% of patients being Rh-positive. The median age of the cohort was 48 years (IQR: 19). While ABO groups showed no significant difference in age, Rh-negative patients were significantly older than Rh-positive patients (52.5 vs. 48.0 years; p = 0.027). No direct association was identified between ABO groups and the overall clinicopathological features such as tumor size or multifocality (p > 0.05). However, significant differences were observed regarding pathologically confirmed lymph node (LN) involvement. Pathologically confirmed LN involvement was significantly more prevalent in the Rh-negative group compared to the Rh-positive group (15.8% vs. 5.5%; p = 0.027). Most notably, a subgroup analysis revealed that patients with the AB blood group had a significantly higher rate of pathologically confirmed LN involvement compared to non-AB groups (15.6% vs. 5.7%; p = 0.028). To confirm the independence of this association, a multivariable logistic regression analysis was performed. After adjusting for potential confounders including age and tumor size, the AB blood group was independently associated with pathologically confirmed LN metastasis in an exploratory multivariable model (OR: 3.114, 95% CI: 1.085-8.938, p = 0.035). These findings suggest that while ABO and Rh blood groups are not significantly associated with most clinicopathological variables in this cohort, they demonstrate specific correlations with nodal disease. These findings may represent exploratory signals that warrant further validation, rather than clinically applicable biomarkers at this stage. Further multicenter prospective studies are warranted to validate these associations across all histological subtypes.
SN - 1472-6823
ER -